PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Immunology and School of Medicine, Tsinghua University, Beijing, China.\', \'Center for Human Disease Immuno-monitoring, Beijing Friendship Hospital, Beijing, China.\', \'College of Basic Medical Science, Jilin University, Changchun, China.\', \'Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China.\', \'Beijing Ditan Hospital, Capital Medical University, and Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, China.\', \'Department of Hematology, Chui Yang Liu Hospital Affiliated to Tsinghua University, Beijing, China.\', \'Department of Cardiology, Chui Yang Liu Hospital Affiliated to Tsinghua University, Beijing, China.\', \'China-Japan Union Hospital, Jilin University, Changchun, China.\', \'Beijing Key Lab for Immunological Research on Chronic Diseases, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.603563
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33603759
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all